CLASS II Device recall · Reported 24 Jun 2020 · FDA Enforcement Report

Regard SRHS Central Line Kit, Sterile recalled

Resource Optimization & Innovation is recalling Regard SRHS Central Line Kit, Sterile, distributed nationwide in the US. The recall was initiated on 4 May 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesItem number 303399REG: lot numbers: 257967, 259035, 260742, 259418, 261252, 261888, 263836, 264669, 268918, 271005, 265730, 270198, and 270567.
Quantity recalled12,640 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2369-2020
FDA event ID
85632
Recalling firm
Resource Optimization & Innovation, Saint Louis, MO
Classification
Class II
Status
Terminated
Recall initiated
4 May 2020
FDA classified
15 Jun 2020
Reported
24 Jun 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

4 May 2020Recall initiated by company
15 Jun 2020Classified by FDA+42 days
24 Jun 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential for the product to exhibit holes in the packaging, which impacts package integrity and potentially compromises a sterile field.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Regard SRHS Central Line Kit, Sterile, 20/case - Product Usage: The Saline Flush Syringes are intended to be used only for the flushing of indwelling of vascular access devices.

Where it was distributed

US Nationwide distribution including in the states of MO, NC.

Nationwide MissouriNorth Carolina

Questions about this recall

Why was it recalled?

There is a potential for the product to exhibit holes in the packaging, which impacts package integrity and potentially compromises a sterile field.

Which lots are affected?

Item number 303399REG: lot numbers: 257967, 259035, 260742, 259418, 261252, 261888, 263836, 264669, 268918, 271005, 265730, 270198, and 270567.

Where was it sold?

US Nationwide distribution including in the states of MO, NC.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 85632
ReportedClassRecallCompanyReasonWhere
CLASS IIRegard SRHS GIC Port A Cath, Sterile, Qty recalledResource Optimization & InnovationSterilityNationwide

More recalls from Resource Optimization & Innovation

All 228

Other Heart & Vascular Devices recalls

All 6,220